Quizartinib is to be funded by the NHS in England for the treatment of some patients with acute myeloid leukaemia (AML), it has been announced.
The tyrosine-kinase blocker gained regulatory approval in March, and will now be available through the...
1 year ago
Many children with B-cell acute lymphoblastic leukaemia (ALL) can be given low intensity therapy, according to a major new US study.
A clinical trial led by researchers from at St Jude Children's Research Hospital, Memphis, Tennessee now suggests...
1 year ago
